Dexlansoprazole【Rating Fetal risk cannot be ruled out】

Gastrointestinal Agents : Agents Used in Peptic Ulcer Disease : Proton Pump Inhibitor
ODEXI1 “Dexilant DR tablet” 60 mg/tab

適應症:治療糜爛性逆流性食道炎維持糜爛性逆流性食道炎已治療後之療效非糜爛性胃食道逆流疾病之症狀治療。

Usual dose:

Erosive esophagitis, Healing of all grades: 60 mg PO QD for up to 8 weeks.

Erosive esophagitis, Maintenance of healing – Heartburn: 30 mg PO QD for up to 6 months.

Gastroesophageal reflux disease, Refractory: 30 mg PO BID.

Gastroesophageal reflux disease, Symptomatic, nonerosive: 30 mg PO QD for 4 weeks.

Related Entries

(Visited 46 times, 1 visits today)